Skip to content
Eyes — Alpha-2 agonist eye dropsATC S01EA05

Brimonidine

Prescription only

Glaucoma drop, also used for redness and rosacea.

Starts working
Varies
Half-life
—
In use since
1996
Pregnancy
Use with caution

Overview

Brimonidine lowers eye pressure in glaucoma. Low-dose drops whiten red eyes, and a gel reduces facial redness from rosacea. Eye allergy develops in some long-term users.

Conditions it's used for

How it works

Reduces fluid production and increases drainage.

Brimonidine belongs to the Alpha-2 agonist eye drops. How Alpha-2 agonist eye drops work: reduce fluid production and increase drainage in the eye.

Uses

  • Glaucoma
  • Eye redness (low dose)
  • Rosacea redness (gel)

Available as: eye drops, gel.

Typical dose

Adults
One drop two or three times a day for glaucoma.

Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.

Side effects

Common

Often mild and may settle with time

  • Allergic eye redness
  • Dry mouth
  • Tiredness

Serious — get medical help

Uncommon, but need prompt attention

  • Breathing problems and drowsiness in infants

Warnings

  • Not for children under 2

Interactions

  • Sedatives — more drowsiness
Check Brimonidine against your own medicines

Pregnancy and breastfeeding

Use with caution

Limited data.

Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.

Brand names

United States
Alphagan P, Lumify, Mirvaso
United Kingdom
Alphagan, Mirvaso
India
Alphagan, Brimocom
Australia
Alphagan

Examples only; many generic versions exist. The same brand name can mean different products in different countries.

Common questions

Can I use redness drops every day?

Occasional use is fine; frequent use can mask an eye problem.

Do I need a prescription for Brimonidine?

Yes — Brimonidine is prescription-only in most countries.

Can I take Brimonidine during pregnancy?

Use with caution. Limited data. Always check with a doctor or midwife.

Sources and official information

Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.